News

Discover how simple lifestyle changes — like exercise, diet, and better sleep — can help reduce symptoms and improve quality ...
Glutamate activates ionotropic glutamate receptors (iGluRs) which include the NMDA, AMPA and kainate receptors, and the metabotropic glutamate receptors (mGluRs) which are coupled to G proteins.
Blocking serotonin transporters with antidepressants boosted CD8 T cell function and enhanced immunotherapy response in mouse ...
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...
Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates ...
Eli Lilly will buy privately held SiteOne Therapeutics in a deal worth as much as $1 billion, the companies said on Tuesday, ...
Cannabis affects the brain and body through the endocannabinoid system, influencing everything from mood to pain management ...
Identifying proteomic signatures of insulin resistance in fasting muscle offers insights for personalized type 2 diabetes ...
Obesity medications in development could improve accessibility and affordability, according to a presenter at Obesity ...
A recently published review explores how diet, gut dysbiosis, and probiotics may influence rosacea symptoms through immune ...
A new experimental painkiller has shown promise in dulling or eliminating pain without the addictive qualities exhibited by ...
Fintel reports that on May 28, 2025, HC Wainwright & Co. initiated coverage of Trevi Therapeutics (NasdaqGM:TRVI) with a Buy ...